Overview
Jane Gibson practices practicing medicine in Southampton, United Kingdom.
Ms. Gibson is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Marginal Zone Lymphoma (MZL), Splenic Neoplasm, Camptodactyly Fibrous Tissue Hyperplasia Skeletal Dysplasia, and Camptodactyly Taurinuria.
She is actively involved in clinical research, co-authoring 56 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jane S. Gibson
Is Jane S. Gibson a top-rated expert for Marginal Zone Lymphoma (MZL)?
MediFind is an objective health platform that identifies experts based on real-world data. Jane S. Gibson is classified as an Advanced expert for Marginal Zone Lymphoma (MZL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jane S. Gibson participate in research or clinical trials?
Yes. Jane S. Gibson has published 54 articles and abstracts on conditions like Marginal Zone Lymphoma (MZL). You can view a list of Jane S. Gibson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Marginal Zone Lymphoma (MZL)Ms. Gibson isAdvanced. Learn about Marginal Zone Lymphoma (MZL).
- Splenic NeoplasmMs. Gibson isAdvanced. Learn about Splenic Neoplasm.
- Experienced
- Age-Related Macular Degeneration (ARMD)Ms. Gibson isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- AlbinismMs. Gibson isExperienced. Learn about Albinism.
- B-Cell LymphomaMs. Gibson isExperienced. Learn about B-Cell Lymphoma.
- Camptodactyly Fibrous Tissue Hyperplasia Skeletal Dysplasia
- Camptodactyly Syndrome Guadalajara Type 1
- Camptodactyly Syndrome Guadalajara Type 2
- Camptodactyly TaurinuriaMs. Gibson isExperienced. Learn about Camptodactyly Taurinuria.
- EndometriosisMs. Gibson isExperienced. Learn about Endometriosis.
- GlaucomaMs. Gibson isExperienced. Learn about Glaucoma.
- Hermansky-Pudlak SyndromeMs. Gibson isExperienced. Learn about Hermansky-Pudlak Syndrome.
- Late-Onset Retinal DegenerationMs. Gibson isExperienced. Learn about Late-Onset Retinal Degeneration.
- MesotheliomaMs. Gibson isExperienced. Learn about Mesothelioma.
- Non-Hodgkin LymphomaMs. Gibson isExperienced. Learn about Non-Hodgkin Lymphoma.
- ObesityMs. Gibson isExperienced. Learn about Obesity.
- Ocular AlbinismMs. Gibson isExperienced. Learn about Ocular Albinism.
- Ocular Hypertension (OHT)Ms. Gibson isExperienced. Learn about Ocular Hypertension (OHT).
- Oculocutaneous AlbinismMs. Gibson isExperienced. Learn about Oculocutaneous Albinism.
- Oculocutaneous Albinism Type 1Ms. Gibson isExperienced. Learn about Oculocutaneous Albinism Type 1.
- Oculocutaneous Albinism Type 2Ms. Gibson isExperienced. Learn about Oculocutaneous Albinism Type 2.
- Pigment-Dispersion SyndromeMs. Gibson isExperienced. Learn about Pigment-Dispersion Syndrome.
- Pseudomyxoma PeritoneiMs. Gibson isExperienced. Learn about Pseudomyxoma Peritonei.
- RhabdomyosarcomaMs. Gibson isExperienced. Learn about Rhabdomyosarcoma.
- X-Linked Infantile NystagmusMs. Gibson isExperienced. Learn about X-Linked Infantile Nystagmus.